References
1 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn. Washington D.C.: American Psychiatric Association 1994.
2 Gillberg C. Coleman M. The Biology of the Autistic Syndromes 2nd edn. London: Mac Keith Press 1992.
3 Filipek P. Accardo P. Baranek G. et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999; 29(6): 439-484.
4 Bailey A. Phillips W. Rutter M. Autism: towards an integration of clinical genetic neuro-psychological and neurobiological perspectives. J Child Psychol Psychiatry 1996; 37(1): 89-126.
5 Suzuki T. Takemoto T. I. Kashiwazaki H. Miyama T. Metabolic fate of ethylmercury salts in man and animal. Mercury Mercurials and Mercaptans Ch 12; 209-233. Miller M. W. Clarkson T. W. eds. Springfield: Charles C. Thomas 1973. 6 Halsey N. A. Perspective on the use of thimerosal-containing vaccines. Presentation at the National Vaccine Advisory Committee Workshop on Thimerosal and Vaccines August 11-12 1999. Institute of Vaccine Safety website;. 7 Egan W. M. Thimerosal in Vaccines. Presentation to the FDA September 14 1999.
8 Gosselin R. E. Smith R. P. Hodge H. C. Mercury. Clinical Toxicology of Commercial Products Section III Therapeutic Index5th edn. Baltimore: Williams & Wilkins 1984: 262-271.
9 Dales L. D. The neurotoxicity of alkyl mercury compounds. Am J Med 1972; 53: 219-232.
10 Koos B. J. Longo L. D. Mercury toxicity in the pregnant woman fetus and newborn infant. Am J Obstet Gynecol 1976: 126(3): 390-406.
11 Warkany J. Hubbard D. H. Acrodynia and mercury. J Pediatrics 1953: 42; 365-386.
12 McDougle C. J. Brodkin E. S. Yeung P. P. Naylor S. T. Cohen D. J. Price L. H. Risperidone in adults with autism or pervasive developmental disorder. J Child Adolesc Psychopharmacol 1995; 5(4): 273-282.
13 Jaselskis C. Cook E. Fletcher K. Bennett L. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Pharmacol 1992.
14 Piven J. Palmer P. Psychiatric disorder and the broad autism phenotype: evidence from a family study of multiple-incidence autism families. Am J Psychiatry 1999; 156(4): 557-563.
15 Clarke D. Baxter M. Perry D. Prasher V. The diagnosis of affective and psychotic disorders in adults with autism: seven case reports. Autism 1999; 3(2): 149-164.
16 Muris P. Steerneman P. Merckelbach H. Holdrinet I. Meesters C. Comorbid anxiety symptoms in children with pervasive developmental disorders. J Anxiety Disord 1998; 12(4): 387-393.
17 Wing L. Attwood A. Syndromes of autism and atypical development. Handbook of Autism and Pervasive Developmental Disorders. John Wiley & Sons Inc. 1987: 3-19.
18 Fagala G. E.Wigg C. L. Psychiatric manifestations of mercury poisoning. J Am Acad Child Adolesc Psychiatry 1992; 31(2): 306-311.
19 Kark R. A. Poskanzer D .C. Bullock J. D. Boylen G. Mercury poisoning and its treatment with N-acetyl-D. L-penicillamine. N Engl J Med 1971; 285: 10-16.
20 White R. F. Feldman R. G. Moss M. B. Proctor S. P. Magnetic resonance imaging (MRI) neurobehavioral testing and toxic encephalopathy: two cases. Environ Res 1993; 61: 117-123.
21 O'Carroll R. E. Masterton G. Dougnall N. Ebmeier K. P. The neuropsychiatric sequelae of mercury poisoning: The Mad Hatters disease revisited. Br J Psychiatry 1995; 167(1): 95-98.
22 Florentine M. J. Sanfilippo II D. J. Grand rounds: elemental mercury poisoning. Clin Pharm 1991; 10: 213-221.
23 Amin-Zaki L. Elhassani S. Majeed M. A. Clarkson T. W. Doherty R. A. Greenwood M. Intra-uterine methylmercury poisoning in Iraq. Pediatrics 1974; 54(5) 587-595.
24 Amin-Zaki L. Majeed M. A. Elhassani S. B. Clarkson T. W. Greenwood M. R. Doherty R. A. Prenatal methylmercury poisoning. Am J Disabled Child 1979; 133: 172-177.
25 Joselow M. M. Louria D. B. Browder A. A. Mercurialism: environmental and occupational aspects. Ann Intern Med 1972; 76: 119-130.
26 Smith D. Mental Effects of Mercury Poisoning. Presentation before the Section on Family Practice Southern Medical Association 71st Annual Scientific Assembly November 6-9 1977.
27 Lowell J. A. Burgess S. Shenoy S. Curci J. A. Peters M. Howard T. K. Mercury poisoning associated with high-dose hepatitis-B immune globulin administration after liver transplantation for chronic hepatitis B. Liver Transpl Surg 1996; 2(6): 475-478.
28 Clarkson T. The toxicology of mercury. Crit Rev Clin Lab Sci 1997; 34(3): 369-403.
29 Camerino D. Cassito M.G. Desideri E. Angotzi G. Behavior of some psychological parameters of a population of a Hg extraction plant. Clin Toxicol 1981; 18(11): 1299-1309.
30 Snyder R. D. The involuntary movements of chronic mercury poisoning. Arch Neurol 1972; 26: 379-381.
31 Vroom F. Q. Greer M. Mercury vapour intoxication. Brain 1972; 95: 305-318.
32 Adams C. R. Ziegler D. K. Lin J. T. Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA 1983; 250: 642-643.
33 Cuomo V. Ambrosi L. Annau Z. Cagiano R. Brunello N. Racagni G. Behavioural and neurochemical changes in offspring of rats exposed to methylmercury during gestation. Neuobehav Toxicol Teratol 1984; 6(3): 249-254.
34 Tsubaki T. Irukayama K. eds. Minamata Disease. Elsevier Scientific Publishing Co. 1977.
35 Elsner J. Testing strategies in behavioral teratology. III. Microanalysis of behavior. Neurobehav Toxicol Teratol 1986; 8: 573-584.
36 Dawson G. Brief report: neuropsychology of autism: a report on the state of the science. J Autism Dev Disord 1996; 26(2): 179-184.
37 Pierce P. E. Thompson J. F. MPH Likosky W. H. MD Nickey L. N. MD Barhtel W. F. Hinman A. R. MD MPH. Alkyl mercury poisoning in humans. JAMA 1972; 220(11): 1439-1442.
38 Grandjean P. Weihe P. White R. F. Debes F. Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ Res 1998; 77(2): 165-172.
39 Amin-Zaki L. Majeed M. A. Clarkson T. W. Greenwood M. R. Methylmercury poisoning in Iraqi children: clinical observations over two years. British Medical Journal 1978; March 1: 613-616.
40 Clarkson T. W. Mercury: major issues in environmental health. Environ Health Perspect 1992; 100: 31-38.
41 Kugler B. The differentiation between autism and Asperger syndrome. Autism 1998; 2(1): 11-32.
42 Teitelbaum P. Teitelbaum O. Nye J. Fryman J. Maurer R. G. Movement analysis in infancy may be useful for early diagnosis of autism. Proc Natl Acad Sci U S A 1998; 95: 13982-13987.
43 Tsai L. Y. Brief report: comorbid psychiatric disorders of autistic disorder. J Autism Dev Disord 1996; 26(2): 159-164.
44 Cesaroni L. Garber M. Exploring the experience of autism through firsthand accounts. J Autism Dev Disord 1991; 21(3): 303-313.
45 Farnsworth D. Pink Disease Survey Results. Pink Disease Support Group Site 1997;
46 Brasic J. R. Movements in autistic disorder. Med Hypoth 1999; 53: 48-49.
47 Rosenhall U. Nordin V. Sandstrom M. Ahlsen G. Gillberg C. Autism and hearing loss. J Autism Dev Disord 1999; 29(5): 349-358.
48 Roux S. Adrien J-L. Bruneau N. Malvy J. Barthelemy C. Behavior profiles within a population of 145 children with autism using the Behaviour Summarized Evaluation scale: influence of developmental age. Autism 1998; 2(4): 345-366.
49 Baranek G. Autism during infancy: a retrospective video analysis of sensory-motor and social behaviors and 9-12 months of age. J Autism Dev Disord 1999; 29(3): 213-224.
50 ONeill M. Jones R. S. P. Sensory-perceptual abnormalities in autism: a case for more research J Autism Dev Disord 1997; 27(3): 283-293.
51 Sperry V. W. Family and personal section: from the inside out - a view of the world as seen by one with Asperger syndrome. Autism 1998; 2(1): 81-86
52 Cass H. Visual impairment and autism: current questions and future research. Autism 1998; 2(2): 117-138.
53 Manser N. Neville's (a Pinkie) Recollection of Pink Disease. Pink Disease Support Group; www.users.bigpond.com/difarnsworth.
54 Minshew N. J. Brief report: brain mechanisms in autism: functional and structural abnormalities. J Autism Dev Disord 1996; 26(2): 205-209.
55 Plioplys A. V. Hemmens S. E. Regan C. M. Expression of a neural cell adhesion molecule serum fragment is depressed in autism. J Neuropsychiatry Clin Neurosci 1990; 2(4): 413-417.
56 Sarafian T. A. Bredesen D. E. Verity M. A. Cellular resistance to methylmercury. Neurotoxicology 1996 Spring Abstract; 17(1): 27-36.
57 Hassett-Sipple B. Swartout J. Schoeny R. Vol. V. Health effects of mercury and mercury compounds. Mercury Study Report to Congress. Environmental Protection Agency (EPA) December 1997.
58 Pendergrass J. C. Haley B. E. Vimy M. J. Winfield S. A. Lorscheider F. L. Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain. Neurotoxicology 1997; 18(2): 315-324.
59 Dey P. M. Gochfeld M. Reuhl K. R. Developmental methylmercury administration alters cerebellar PSA-NCAM expression and Golgi sialyltransferase activity. Brain Res 1999; 845(2): 139-151.
60 Courchesne E. et al. More evidence links autism cerebellar defects. reviewed in Autism Research Review International 1994; 8(2): 17.
61 Ritvo E. R. Freeman B. J. Scheibel A. B. et al. Lower Purkinje cell counts in the cerebella of four autistic subjects: intitial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry 1986; 143: 862-866.
62 Hoon A. H. Riess A. L.